Pieter Van der Veken

University of Antwerp — Belgium

Medicine · Health Sciences

45h-index6.8kcitations241works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Peptidase Inhibition and Analysis(94), Neuropeptides and Animal Physiology(55), Diabetes Treatment and Management(25), Protease and Inhibitor Mechanisms(20), Signaling Pathways in Disease(17)

Publications241 total

A Novel Fibroblast Activation Protein‐Based Algorithm to Assess Fibrosis in Metabolic Dysfunction–Associated Steatotic Liver Disease
Journal of Gastroenterology and Hepatology·2026Open Access
Vectorized ULK1/2 and VPS34 Inhibitors for Tissue-Selective Autophagy Inhibition in Oncology
Journal of Medicinal Chemistry·2026
Synthesis and preclinical evaluation of a 18F- and 211At-labeled FAP inhibitor for theranostic tumor targeting
Nuclear Medicine and Biology·2025
18F-labelling of T cells for in vivo evaluation of CAR T cell therapy
Nuclear Medicine and Biology·2025Open Access
One-step radiolabeling of a FAP inhibitor via 18F-19F isotope exchange and preclinical evaluation using PET imaging
Nuclear Medicine and Biology·2025Open Access
Selective and Orally Bioavailable Dipeptidyl Peptidase 9 Inhibitors with Potent Pyroptosis Induction Properties
Journal of Medicinal Chemistry·2025
Fibroblast activation protein promotes natural killer cell invasion and tumor infiltration
The Journal of Immunology·2025
Structure–Property Investigation of New “KetoFAPI” Inhibitors of Fibroblast Activation Protein (FAP): Discovery of Highly Potent, Selective Compounds with Prolonged Residence Times and Promising Radiotheranostic Potential
Journal of Medicinal Chemistry·2025· 2 cited
Synthesis and Preclinical Evaluation of Druglike <sup>18</sup>F-Labeled Fibroblast Activation Protein (FAP) Inhibitors with Enhanced Tumor Retention
Bioconjugate Chemistry·2025· 2 cited
Biarylacetamides: a novel class of late-stage autophagy inhibitors
Autophagy Reports·2025Open Access
Fibroblast activation protein on human natural killer cells: insights from natural killer cell activation and crosstalk with cancer-associated fibroblasts
Journal of Leukocyte Biology·2025
Highly potent dipeptidyl peptidase 8/9 (DPP8/9) inhibitors designed via relative binding free energy calculations
European Journal of Medicinal Chemistry·2025· 2 cited
Dipeptidyl Peptidase 9 in Human Leukocytes: Novel Inhibitors Induce Caspase‐1‐ and Gasdermin‐Dependent Cell Death
European Journal of Immunology·2025· 2 citedOpen Access
Author response for "Dipeptidyl Peptidase 9 in Human Leukocytes: Novel Inhibitors Induce Caspase‐1‐ and Gasdermin‐Dependent Cell Death"
2025
Author response for "Dipeptidyl Peptidase 9 in Human Leukocytes: Novel Inhibitors Induce Caspase‐1‐ and Gasdermin‐Dependent Cell Death"
2025
The prolyl oligopeptidase and α-synuclein connection revisited
Biochimie·2025· 4 cited
Oxazole-Based Ferroptosis Inhibitors with Promising Properties to Treat Central Nervous System Diseases
Journal of Medicinal Chemistry·2025· 7 citedOpen Access
An Interdisciplinary Approach Provides Insights into the Pronounced Selectivity of Compound 42 for DPP9
ChemMedChem·2024
Cosolvent Molecular Dynamics Applied to DPP4, DPP8 and DPP9: Reproduction of Important Binding Features and Use in Inhibitor Design
Journal of Chemical Information and Modeling·2024· 1 citedOpen Access
Development of caspase-3-selective activity-based probes for PET imaging of apoptosis
EJNMMI Radiopharmacy and Chemistry·2024· 4 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

Koen Augustyns(35), Anne‐Marie Lambeir(19), Ingrid De Meester(19), Jurgen Joossens(13), Achiel Haemers(13), Simon Scharpé(7), Kristel Senten(5), Reinhilde Vermeylen(4), Willy Maenhaut(4), Magda Claeys(4), Koen Jansen(4), Jonathan D. Cheng(4), Paul Cos(4), Louis Maes(4), Marie-Berthe Maes(4), Sam Hofmans(4), Hans De Winter(4), Peter Vandenabeele(4), Sigrid Stroobants(4), Veerle Matheeussen(4)